Differential regulation of angiotensin peptide levels in plasma and kidney of the rat

Hypertension

Volumn 18, Issue 6, 1991, Pages 763-773

  Campbell, Duncan J ^a   Lawrence, Anne C ^a   Towrie, Amanda ^a   Kladis, Athena ^a   Valentijn, Anthony J ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensinogen; Liver; Messenger RNA; Renin; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN III; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRINKING WATER; MESSENGER RNA; PEPTIDE; PERINDOPRIL;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; KIDNEY METABOLISM; MALE; NONHUMAN; PEPTIDE ANALYSIS; PLASMA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSINOGEN; ANGIOTENSINS; ANIMAL; ANTIHYPERTENSIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INDOLES; KIDNEY; LIVER; MALE; PEPTIDYL-DIPEPTIDASE A; PERINDOPRIL; RADIOIMMUNOASSAY; RATS; RATS, INBRED STRAINS; RENIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026409556     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.18.6.763     Document Type: Article

References (63)

1. Skeggs LT, Khan JR, Lentz KE, Shumway NP: The preparation, purification, and amino acid sequence of a polypeptide renin substrate. J Exp Med 1957;106:439-453
2. Skeggs LT, Lentz KE, Kahn JR, Shumway NP: The synthesis of a tetradecapeptide renin substrate. J Exp Med 1958;108: 283-296
3. Lentz KE, Skeggs LT, Woods KR, Kahn JR, Shumway NP: The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I. J Exp Med 1956;104:183-191
4. Di Nicolantonio R, Doyle AE: Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats. J Cardiovasc Pharmacol 1985;7:937-942
5. Sweet CS, Gross DM, Arbegast PT, Gaul SL, Britt PM, Ludden CT, Weitz D, Stone CA: Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor. J Pharmacol Exp Ther 1981;216:558-566
6. Cohen ML, Kurz KD: Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J Pharmacol Exp Ther 1982;220:63-69
7. Unger T, Ganten D, Lang RE, Scholkens BA: Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1985;7:36-41
8. Chen X, Pitt BR, Maolli R, Gillis CN: Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits. J Pharmacol Exp Ther 1984;229:649-653
9. Nussberger J, Brunner DB, Waeber B, Brunner HR: Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hypertension 1986;8:476-482
10. Nussberger J, Brunner DB, Waeber B, Brunner HR: True versus immunoreactive angiotensin II in human plasma Hypertension 1985;7(suppl I):I-1-I-7
11. Juillerat L, Nussberger J, Ménard J, Mooser V, Christen Y, Waeber B, Graf P, Brunner HR: Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 1990;16:564-572
12. Mento PF, Wilkes BM: Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension 1987; 9(suppl III):III-42-III-48
13. Mento PF, Holt WF, Murphy WR, Wilkes BM: Combined renin and converting enzyme inhibition in rats. Hypertension 1989;13:741-748
14. Campbell DJ: The site of angiotensin production. J Hypertens 1985;3:199-207
15. Campbell DJ: Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6
16. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH: Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990;15:44-55
17. Changaris DG, Miller JJ, Levy RS: Angiotensin II generated by a human renal carboxypeptidase. Biochem Biophys Res Commun 1986;138:573-579
18. 10]-angiotensin I. Peptides 1989;10:489-492
19. Drummer OH, Kourtis S, Johnson H: Formation of angiotensin II and other angiotensin peptides from des-Leu 10-angiotensin I in rat lung and kidney. Biochem Pharmacol 1988;22: 4327-4333
20. Drummer OH, Kourtis S, Johnson H: Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II. Biochem Pharmacol 1990;39:513-518
21. Unger T, Ganten D, Lang RE, Scholkens BA: Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1984;6: 872-880
22. Unger T, Moursi M, Ganten D, Hermann K, Lang RE: Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: Comparison with enalapril (MK421) and ramipril (HOE498). J Cardiovasc Pharmacol 1986;8:276-285
23. Cushman DW, Wang FL, Fung WC, Harvey CM, DeForrest JM: Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Am J Hypertens 1989;2:294-306
24. Jackson B, Cubela RB, Johnston CI: Inhibition of tissue angiotensin converting enzyme by perindopril: In vivo assessment in the rat using radioinhibitor binding displacement. J Phantiacol Exp Ther 1988;245:950-955
25. Antonaccio MJ, High JP, Rubin B, Schaeffer T: Contribution of the kidneys but not adrenal glands to the acute antihypertensive effects of captopril in spontaneously hypertensive rats. Clin Sci 1979;57:127s-130s
26. Richer C, Doussau M-P, Giudicelli J-F: Influence of captopril and enalapril on regional vascular alpha-adrenergic receptor reactivity in SHR. Hypertension 1984;6:666-674
27. Harrap SB, Nicolaci JA, Doyle AE: Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin Exp Pharmacol Physiol 1986;13:753-765
28. Lawrence AC, Evin G, Kladis A, Campbell DJ: An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: Measurement of eight angiotensin peptides in human plasma. J Hypertens 1990;8: 715-724
29. Szelke M, Leckie B, Hallett A, Jones DM, Sueiras J, Atrash B, Lever AF: Potent new inhibitors of human renin. Nature 1982;299:555-557
30. Szelke M, Leckie B, Tree M, Brown A, Grant J, Hallett A, Hughes M, Jones DM, Lever AF: H-77: A potent new renin inhibitor: In vitro and in vivo studies. Hypertension 1982; 4(suppl II):II-59-II-69
31. Campbell DJ, Kladis A: Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man. J Hypertens 1990;8:165-172
32. Thatcher RL, Butty JS, Whitworth JA, Hunt VDU, Shaw PF, Skinner SL, Horowitz JD: Potential functions of plasma prorenin: Regional activation and tissue extraction. Clin Exp Hypertens [A] 1987;9:1415-1434
33. Johansen KB, Marstein S, Aas P: Automated method for the determination of angiotensin-converting enzyme in serum. Scand J Clin Lab Invest 1987;47:411-414
34. Wallis CJ, Printz MP: Adrenal regulation of regional brain angiotensinogen content. Endocrinology 1980;106:337-342
35. Campbell DJ, Habener JF: Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986;78:31-39
36. Campbell DJ, Habener JF: Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: Quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 1987;121:1616-1626
37. Burnham CE, Hawelu-Johnson CL, Frank BM, Lynch KR: Molecular cloning of rat renin cDNA and its gene. Proc Natl Acad Sci USA 1987;84:5605-5609
38. Gorman C, Padmanabhan R, Howard BH: High efficiency DNA-mediated transformation of primate cells. Science 1983; 221:551-553
39. Armitage P: Statistical Methods in Medical Research. Oxford, Blackwell Scientific Publications, 1971, pp 1-504
40. Mendelsohn FAO: Evidence for the local occurrence of angiotensin II in rat kidney and its modulation by dietary sodium intake and converting enzyme blockade. Clin Sci 1979;57:173-179
41. Reams G, Villarreal D, Bauer JH: Intrarenal metabolism of angiotensin II. Am J Physiol 1990;258:F1510-F1515
42. Lindop GBM, Lever AF: Anatomy of the renin-angiotensin system in the normal and pathological kidney. Histopathology 1986;10:335-362
43. Morgan T, Davis JM: Renin secretion at the individual nephron level. Pflugers Arch 1975;359:23-31
44. Hosie KF, Brown JJ, Harper AM, Lever AF, Macadam RF, MacGregor J, Robertson JIS: The release of renin into the renal circulation of the anaesthetized dog. Clin Sci 1970;38: 157-174
45. Lever AF, Peart WS: Renin and angiotensin-like activity in renal lymph. J Physiol (Lond) 1962;160:548-563
46. Mendelsohn FAO: A method for measurement of angiotensin II in tissues and its application to rat kidney. Clin Sci Mol Med 1976;51:111-125
47. De Silva PE, Husain A, Smeby RR, Khairallah PA: Measurement of immunoreactive angiotensin peptides in rat tissues: Some pitfalls in angiotensin II analysis. Anal Biochem 1988; 174:80-87
48. Matsushima Y, Kawamura M, Akabane S, Imanishi M, Kuramochi M, Ito K, Omae T: Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats. J Hypertens 1988;6: 791-796
49. Seikaly MG, Arant BS Jr, Seney FD Jr: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990;86:1352-1357
50. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990;265:22348-22357
51. Clauser E, Bouhnik J, Gonzalez MF, Corvol P, Menard J: Influence of converting-enzyme inhibition on rat desangiotensin I-angiotensinogen. Am J Physiol 1984;246: E129-E133
52. Misumi J, Gardes J, Gonzalez M-F, Corvol P, Menard J: Angiotensinogen's role in ANG formation, renin release, and renal hemodynamics in isolated perfused kidney. Am J Physiol 1989;256:F719-F727
53. Hollenberg NK, Williams GH, Burger B, Chenitz W, Hoosmand I, Adams DF: Renal blood flow and its response to angiotensin II: An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women. Circ Res 1976;38:35-40
54. Nakamura N, Soubrier F, Menard J, Panthier J-J, Rougeon F, Corvol P: Nonproportional changes in plasma renin concentration, renal renin content, and rat renin messenger RNA. Hypertension 1985;7:855-859
55. Iwao H, Fukui K, Kim S, Nakayama K, Ohkubo H, Nakanishi S, Abe Y: Sodium balance effects on renin, angiotensinogen, and atrial natriuretic polypeptide mRNA levels. Am J Physiol 1988;255:E129-E136
56. Gomez RA, Lynch KR, Chevalier RL, Wilfong N, Everett A, Carey RM, Peach MJ: Renin and angiotensinogen gene expression in maturing rat kidney. Am J Physiol 1988;254: F582-F587
57. Nakamura A, Iwao H, Fukui K, Kimura S, Tamaki T, Nakanishi S, Abe Y: Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am J Physiol 1990;258: E1-E6
58. Baker KM, Chemin MI, Wixson SK, Aceto JF: Reninangiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990;259:H324-H332
59. Klett C, Muller F, Gierschik P, Hackenthal E: Angiotensin II stimulates angiotensinogen synthesis in hepatocytes by a pertussis toxin-sensitive mechanism. FEBS Lett 1990;259:301-304
60. Schunkert H, Ingelfinger JR, Dzau VJ: Evolving concepts of the intrarenal renin-angiotensin system in health and disease: Contributions of molecular biology. Renal Physiol Biochem 1991;14:146-154
61. Kohara K, Brosnihan KB, Chappell MC, Khosla MC, Ferrario CM: Angiotensin-(1-7): A member of circulating angiotensin peptides. Hypertension 1991;17:131-138
62. Fyhrquist F, Gronhagen-Riska C, Hortling L, Forslund T, Tikkanen I: Regulation of angiotensin converting enzyme. J Hypertens 1983;1(suppl 1):25-30
63. Dellenback RJ, Muelheims GH: Red blood cell volume and distribution before and after bleed-out in the rat. Am J Physiol 1960;198:1177-1180